Skip to main content
. 2021 Aug 19;23:98. doi: 10.1186/s12968-021-00789-2

Table 1.

Overall demographics

rTOF patients (n = 58) RV dilation patients (n = 28) p Normal controls (n = 12) p
Demographics
 Age (years), IQR 21.7 (12.2–29.6) 11.5 (4.0–15.5)  < 0.001 13.9 (9.1–17.7) 0.038
 Female 30 (51%) 14 (50%) 6 (50%)
 BSA (m2) 1.5 ± 0.40 1.2 ± 0.6  < 0.001 1.4 ± 0.5 ns
Native anatomy

TOF-PS 47 (84%)

TOF-PA 11 (16%)

PAPVR 24 (85%)

2° ASD 4 (15%)

CMR data
 RVEDV (mL) 203 ± 81 165 ± 110 ns 131 ± 55 0.0017
 RVEDVI (mL/m2) 131 ± 33 148 ± 57 ns 86 ± 15  < 0.001
 RVESVI (mL/m2) 65 ± 21 61 ± 29 ns 38 ± 10  < 0.001
 RVEF (%) 51.1% ± 5.5% 60.4% ± 6.1%  < 0.001 60.0% ± 5.8%  < 0.001
 PR% 27.9% ± 16.4% 0.0 ± 0.04%  < 0.001 0.0 ± 0.03%  < 0.001
 Qp:Qs 1.0 ± 0.05 2.5 ± 1.4  < 0.001 1.0 ± 0.08 ns

Fifty-eight repaired tetralogy of Fallot (rTOF) patients, 28 patients with right ventricular (RV) dilation and twelve normal controls were included. RV dilation patients had either partial anomalous pulmonary venous return (PAPVR) or large secundum type atrial septal defects (2° ASD). There was selection bias in that rTOF patients tended to be older and larger than RV dilation patients, although had similar indexed right ventricular end-diastolic volume index (RVEDVI) and RV end-systolic volume index (RVESVI)

BSA body surface area, RVEF right ventricular ejection fraction, PR% pulmonary regurgitation percent